← Back to Clinical Trials
Recruiting NCT06866834

NCT06866834 Examination of the Effect of Nocturia on Pelvic Floor Symptoms, Sleep Parameters and Quality of Life in Women with Urinary Incontinence

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06866834
Status Recruiting
Phase
Sponsor Gulhane School of Medicine
Condition Women
Study Type OBSERVATIONAL
Enrollment 102 participants
Start Date 2025-01-01
Primary Completion 2025-05-01

Trial Parameters

Condition Women
Sponsor Gulhane School of Medicine
Study Type OBSERVATIONAL
Phase N/A
Enrollment 102
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2025-01-01
Completion 2025-05-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Urinary incontinence (UI), a common issue, is the involuntary leakage of urine that negatively affects individuals socially, physically, and psychologically, leading to a decreased quality of life. Nocturia, which is often seen alongside UI, has similar adverse effects. Nocturia refers to the number of urinations during the main sleep period, and it should be accompanied by the intention to fall back asleep after waking up. Nocturia can arise from factors such as sleep disorders and circadian rhythm disturbances. The circadian rhythm regulates the body's biological functions, and this rhythm varies from person to person, creating chronotypes. There is a strong relationship between sleep and nocturia because nocturia leads to deep sleep loss, an increased risk of metabolic diseases, decreased sleep quality and sleep efficiency, and an increase in the number of awakenings after sleep onset. It is necessary to distinguish whether nocturia, which has a comprehensive impact, affects pelvic floor symptoms, chronotype, sleep quality, fatigue, sleepiness, and quality of life in women with UI. Therefore, the aim of this study is to examine the effect of nocturia on pelvic floor symptoms, chronotype, sleepiness, sleep quality, fatigue, and quality of life in women with UI.

Eligibility Criteria

Inclusion Criteria: Inclusion Criteria for the Group with Nocturia: * Being 18 years of age or older * Being female * Have been diagnosed with urinary incontinence * Wake up during the main sleep period to relieve the need to urinate, with the intention of returning to sleep or falling asleep again after each urination Inclusion Criteria for the Group without Nocturia: * Being 18 years of age or older * Being female * Have been diagnosed with urinary incontinence Exclusion Criteria: Exclusion Criteria for the Group with Nocturia: * Diagnosis of a sleep disorder * Diagnosis of any neurological disease * Chronic kidney disease * Diagnosis of diabetes * Use of sleep medications * Use of antidepressants * Use of diuretic medications * Use of any medication for urinary incontinence * Hormone replacement therapy * Pregnancy or having given birth within the last six months * Having had a urinary tract infection in the last three months * Presence of prolapse greater than stage 2 * History of

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology